<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18019/1028-4427-2026-32-1-31-37</article-id><article-id custom-type="elpub" pub-id-type="custom">genort-3419</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Перспективы применения ацетилсалициловой кислоты в комбинации с антибактериальными препаратами против ведущих возбудителей остеомиелита</article-title><trans-title-group xml:lang="en"><trans-title>Prospects for using acetylsalicylic acid in combination with antibacterial drugs against the leading pathogens of osteomyelitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2012-3115</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шипицына</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shipitsyna</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шипицына Ирина Владимировна — кандидат биологических наук, ведущий научный сотрудник.</p><p>Курган</p></bio><bio xml:lang="en"><p>Irina V. Shipitsyna — Candidate of Biological Sciences, Leading Researcher.</p><p>Kurgan</p></bio><email xlink:type="simple">ivschimik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2408-4352</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Осипова Елена Владимировна — кандидат биологических наук, старший научный сотрудник.</p><p>Курган</p></bio><bio xml:lang="en"><p>Elena V. Osipova — Candidate of Biological Sciences, Senior Researcher.</p><p>Kurgan</p></bio><email xlink:type="simple">E-V-OsipovA@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7434-1404</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шастов</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Shastov</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шастов Александр Леонидович — кандидат медицинских наук, старший научный сотрудник.</p><p>Курган</p></bio><bio xml:lang="en"><p>Alexander L. Shastov — Candidate of Medical Sciences, Senior Researcher.</p><p>Kurgan</p></bio><email xlink:type="simple">alshastov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр травматологии и ортопедии имени академика Г.А. Илизарова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ilizarov National Medical Research Centre for Traumatology and Orthopedics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2026</year></pub-date><volume>32</volume><issue>1</issue><fpage>31</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шипицына И.В., Осипова Е.В., Шастов А.Л., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Шипицына И.В., Осипова Е.В., Шастов А.Л.</copyright-holder><copyright-holder xml:lang="en">Shipitsyna I.V., Osipova E.V., Shastov A.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/3419">https://www.ilizarov-journal.com/jour/article/view/3419</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Ацетилсалициловая кислота (АСК) — один из перспективных кандидатов для усиления действия антибактериальных препаратов.</p><p>Цель работы — оценить in vitro влияние аспирина в комбинации с антибактериальными препаратами на рост микробных культур клинически значимых штаммов бактерий при остеомиелите.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Объект исследования — клинически значимые штаммы бактерий K. pneumoniae (n = 12), P. aeruginosa (n = 12), S. aureus (n = 12), S. epidermidis (n = 12), выделенные из ран пациентов c хроническим остеомиелитом. Эксперимент разделен на четыре серии: контрольная группа, группы с АСК, антибиотиком, АСК и антибиотиком. Антибактериальное действие оценивали по отсутствию зоны роста бактерий вокруг дисков.</p></sec><sec><title>Результаты</title><p>Результаты. При совместной инкубации ACK (0,05 %) с грамотрицательными бактериями (K. pneumoniae, P. aeruginosa) на чашках Петри отсутствовал рост микроорганизмов. В случае с бактериями S. aureus количество КОЕ было снижено по сравнению с контрольной группой. На чашках с S. epidermidis отсутствовал рост. При совместной инкубации полимиксина с P. aeruginosa на чашках Петри регистрировали незначительный рост бактерий, в случае с K. pneumoniae наблюдали лишь отдельные колонии. При инкубации совместно с полимиксином и аспирином (0,03 %) на чашках с K. pneumoniae роста микроорганизмов не было, на чашках с P. aeruginosa отмечали незначительный рост. Гентамицин подавлял рост бактерий S. aureus (на чашках отмечали незначительное количество бактерий). АСК (0,03 %) усиливал бактерицидные свойства гентамицина (на чашках отсутствовал рост бактерий).</p></sec><sec><title>Обсуждение</title><p>Обсуждение. Отсутствие под действием АСК роста на чашках c бактериями S. epidermidis, даже без антибиотиков, позволяет предположить, что одним из механизмов действия может быть подавление адгезии и формирование биоплёнки. Наличие выраженного эффекта АСК в отношении грамотрицательных бактерий (K. pneumoniae, P. aeruginosa) может быть связано с воздействием на наружную мембрану микробных клеток, в то время как на грамположительные бактерии (S. aureus), аспирин оказывал меньшее влияние, лишь снижая метаболическую активность.</p></sec><sec><title>Заключение</title><p>Заключение. Наше исследование продемонстрировало, что ацетилсалициловая кислота in vitro проявляет синергизм с рядом антибиотиков, значительно усиливая их бактерицидную активность в отношении клинических изолятов, ассоциированных с остеомиелитом.</p></sec></abstract><trans-abstract xml:lang="en"><p>Introduction Acetylsalicylic acid (ASA) is one of the promising candidates for enhancing the action of antibacterial drugs.</p><p>Purpose To evaluate in vitro the effect of aspirin in combination with antibacterial drugs on the growth of microbial cultures of clinically significant bacterial strains in osteomyelitis.</p><p>Materials and methods The object of the study is clinically significant bacterial strains K. pneumoniae (n = 12), P. aeruginosa (n = 12), S. aureus (n = 12), S. epidermidis (n = 12), isolated from wounds of patients with chronic osteomyelitis. The experiment was divided into four series: control group; group of ASA administration; group of antibiotic administration; group of ASA + antibiotic administration. Antibacterial effect was assessed by the absence of a bacterial growth zone around the discs.</p><p>Results There was no growth of microorganisms on Petri dishes when ASA (0.05 %) was incubated with gram-negative bacteria (K. pneumoniae, P. aeruginosa). In the case of S. aureus bacteria, the number of CFU was reduced compared to the control group. There was no growth on plates with S. epidermidis. When polymyxin was incubated with P. aeruginosa, slight bacterial growth was recorded on Petri dishes, while only individual colonies were observed with K. pneumoniae. When incubated together with polymyxin and aspirin (0.03 %), there was no growth of microorganisms on plates with K. pneumoniae, while slight growth was noted on plates with P. aeruginosa. Gentamicin suppressed the growth of S. aureus bacteria (an insignificant number of bacteria was noted on the plates). ASA (0.03 %) enhanced the bactericidal properties of gentamicin (there was no bacterial growth on the plates).</p><p>Discussion The absence of growth on plates with S. epidermidis bacteria under the influence of ASA, even without antibiotics, suggests that one of the mechanisms of its action may be the suppression of adhesion and biofilm formation. The presence of a pronounced effect of ASA on gram-negative bacteria (K. pneumoniae, P. aeruginosa) may be associated with the effect on the outer membrane of microbial cells, while aspirin had a lesser effect on gram-positive bacteria (S. aureus) and only reduced metabolic activity.</p><p>Conclusion Our study demonstrated that acetylsalicylic acid exhibits synergism with a number of antibiotics in vitro and significantly enhances their bactericidal activity against clinical isolates associated with osteomyelitis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ацетилсалициловая кислота</kwd><kwd>хронический остеомиелит</kwd><kwd>S. aureus</kwd><kwd>S. epidermidis</kwd><kwd>K. pneumoniae</kwd><kwd>P. aeruginosa</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acetylsalicylic acid</kwd><kwd>chronic osteomyelitis</kwd><kwd>S. aureus</kwd><kwd>S. epidermidis</kwd><kwd>K. pneumoniae</kwd><kwd>P. aeruginosa</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шипицына И.В., Осипова Е.В. Мониторинг ведущей грамположительной микрофлоры и ее антибиотикочувствительности у лиц с хроническим остеомиелитом за трехлетний период. Гений ортопедии. 2022;28(2):189-193. doi: 10.18019/1028-4427-2022-28-2-189-193.</mixed-citation><mixed-citation xml:lang="en">Shipitsyna IV, Osipova EV. Monitoring of the most common gram-positive microflora and its antibiotic sensitivity in persons with chronic osteomyelitis over a three-year period. Genij Ortopedii. 2022;28(2):189-193. doi: 10.18019/1028-4427-2022-28-2-189-193.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang K, Bai YZ, Liu C, et al. Composition of pathogenic microorganism in chronic osteomyelitis based on metagenomic sequencing and its application value in etiological diagnosis. BMC Microbiol. 2023;23(1):313. doi: 10.1186/s12866-023-03046-x.</mixed-citation><mixed-citation xml:lang="en">Zhang K, Bai YZ, Liu C, et al. Composition of pathogenic microorganism in chronic osteomyelitis based on metagenomic sequencing and its application value in etiological diagnosis. BMC Microbiol. 2023;23(1):313. doi: 10.1186/s12866-023-03046-x.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Миронов С.П., Цискарашвили А.В., Горбатюк Д.С. Хронический посттравматический остеомиелит как проблема современной травматологии и ортопедии (обзор литературы). Гений ортопедии. 2019;25(4):610-621. doi: 10.18019/1028-4427-2019-25-4-610-621.</mixed-citation><mixed-citation xml:lang="en">Mironov SP, Tsiskarashvili AV, Gorbatyuk DS. Chronic post-traumatic osteomyelitis as a problem of contemporary traumatology and orthopedics (literature review). Genij Ortopedii. 2019;25(4):610-621. doi: 10.18019/1028-4427-2019-25-4-610-621.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шипицына И.В., Осипова Е.В., Леончук Д.С., Судницын А.С. Мониторинг ведущей грамотрицательной микрофлоры и антибиотикорезистентности при остеомиелите. Гений ортопедии. 2020;26(4):544-547. doi: 10.18019/1028-4427-2020-26-4-544-547.</mixed-citation><mixed-citation xml:lang="en">Shipitsyna IV, Osipova EV, Leonchuk DS, Sudnitsyn AS. Monitoring of gram-negative bacteria and antibiotic resistance in osteomyelitis. Genij Ortopedii. 2020;26(4):544-547. doi: 10.18019/1028-4427-2020-26-4-544-547.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Савилов Е.Д., Анганова Е.В., Носкова О.А., Духанина А.В. Бактериальные биоплёнки при гнойно-септических инфекциях. Acta biomedica scientific. 2019;4(5):38-42. doi: 10.29413/ABS.2019-4.5.6.</mixed-citation><mixed-citation xml:lang="en">Savilov ED, Anganova EV, Noskova OA, Dukhanina AV. Bacteria Biofilms in Purulent-Septic Infections. Acta biomedical scientific. 2019;4(5):38-42. (In Russ.) doi: 10.29413/ABS.2019-4.5.6.]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Гордина Е.М., Божкова С.А. Бактериальные биопленки в ортопедии: проблема и возможные перспективы профилактики. РМЖ. 2021;(8):29-32.</mixed-citation><mixed-citation xml:lang="en">Gordina EM, Bozhkova SA. Bacterial biofilms in orthopedics: the problem and possible prospects for prevention. RMJ. 2021;(8):29-32. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Шипицына И.В., Осипова Е.В. Резистентность ведущих возбудителей хронического остеомиелита. Клиническая лабораторная диагностика. 2022;67(12):723-728. doi: 10.51620/0869-2084-2022-67-12-723-728.</mixed-citation><mixed-citation xml:lang="en">Shipitsyna IV, Osipova EV. Resistance of leading pathogens of chronic osteomyelitis. Russian clinical laboratory diagnostics. 2022;67(12):723-728. doi:10.51620/0869-2084-2022-67-12-723-728. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-293.e1. doi: 10.1016/j.ajog.2017.11.561.</mixed-citation><mixed-citation xml:lang="en">Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-293.e1. doi: 10.1016/j.ajog.2017.11.561.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation. 1999;99(21):2791-2797. doi: 10.1161/01.cir.99.21.2791.</mixed-citation><mixed-citation xml:lang="en">Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation. 1999;99(21):2791-2797. doi: 10.1161/01.cir.99.21.2791.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Amin, Sawsan M.; Ahmed, Insan M.; and Abed, Ahmed N. Аntibacterial effect of acetylsalicylic acid on the efficiency of azithromycin against resistant Salmonella enterica: an in vitro study. Baghdad Sci J. 2025;22:(7): 2254-2263. doi: 10.21123/2411-7986.4992.</mixed-citation><mixed-citation xml:lang="en">Amin, Sawsan M.; Ahmed, Insan M.; and Abed, Ahmed N. Аntibacterial effect of acetylsalicylic acid on the efficiency of azithromycin against resistant Salmonella enterica: an in vitro study. Baghdad Sci J. 2025;22:(7): 2254-2263. doi: 10.21123/2411-7986.4992.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sekar A, Gil D, Tierney P, et al. Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms. J Transl Med. 2024;22(1):102. doi: 10.1186/s12967-024-04871-y.</mixed-citation><mixed-citation xml:lang="en">Sekar A, Gil D, Tierney P, et al. Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms. J Transl Med. 2024;22(1):102. doi: 10.1186/s12967-024-04871-y.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gil D, Daffinee K, Friedman R, et al. Synergistic antibacterial effects of analgesics and antibiotics against Staphylococcus aureus. Diagn Microbiol Infect Dis. 2020;96(4):114967. doi: 10.1016/j.diagmicrobio.2019.114967.</mixed-citation><mixed-citation xml:lang="en">Gil D, Daffinee K, Friedman R, et al. Synergistic antibacterial effects of analgesics and antibiotics against Staphylococcus aureus. Diagn Microbiol Infect Dis. 2020;96(4):114967. doi: 10.1016/j.diagmicrobio.2019.114967.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Di Bella S, Luzzati R, Principe L, et al. Aspirin and Infection: A Narrative Review. Biomedicines. 2022;10(2):263. doi: 10.3390/biomedicines10020263.</mixed-citation><mixed-citation xml:lang="en">Di Bella S, Luzzati R, Principe L, et al. Aspirin and Infection: A Narrative Review. Biomedicines. 2022;10(2):263. doi: 10.3390/biomedicines10020263.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Belfield K, Bayston R, Hajduk N, et al. Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 2017;72(9):2531-2538. doi: 10.1093/jac/dkx192.</mixed-citation><mixed-citation xml:lang="en">Belfield K, Bayston R, Hajduk N, et al. Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 2017;72(9):2531-2538. doi: 10.1093/jac/dkx192.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Abbas HA, Atallah H, El-Sayed MA, El-Ganiny AM. Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus. Arch Microbiol. 2020;202(10):2751-2760. doi: 10.1007/s00203-020-01992-y.</mixed-citation><mixed-citation xml:lang="en">Abbas HA, Atallah H, El-Sayed MA, El-Ganiny AM. Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus. Arch Microbiol. 2020;202(10):2751-2760. doi: 10.1007/s00203-020-01992-y.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gerner E, Almqvist S, Werthén M, Trobos M. Sodium salicylate interferes with quorum-sensing-regulated virulence in chronic wound isolates of Pseudomonas aeruginosa in simulated wound fluid. J Med Microbiol. 2020;69(5):767-780. doi: 10.1099/jmm.0.001188.</mixed-citation><mixed-citation xml:lang="en">Gerner E, Almqvist S, Werthén M, Trobos M. Sodium salicylate interferes with quorum-sensing-regulated virulence in chronic wound isolates of Pseudomonas aeruginosa in simulated wound fluid. J Med Microbiol. 2020;69(5):767-780. doi: 10.1099/jmm.0.001188.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Leão C, Borges A, Simões M. NSAIDs as a Drug Repurposing Strategy for Biofilm Control. Antibiotics (Basel). 2020;9(9):591. doi: 10.3390/antibiotics9090591.</mixed-citation><mixed-citation xml:lang="en">Leão C, Borges A, Simões M. NSAIDs as a Drug Repurposing Strategy for Biofilm Control. Antibiotics (Basel). 2020;9(9):591. doi: 10.3390/antibiotics9090591.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hannachi N, Baudoin JP, Prasanth A, et al. The distinct effects of aspirin on platelet aggregation induced by infectious bacteria. Platelets. 2020;31(8):1028-1038. doi: 10.1080/09537104.2019.1704717.</mixed-citation><mixed-citation xml:lang="en">Hannachi N, Baudoin JP, Prasanth A, et al. The distinct effects of aspirin on platelet aggregation induced by infectious bacteria. Platelets. 2020;31(8):1028-1038. doi: 10.1080/09537104.2019.1704717.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chabert A, Damien P, Verhoeven PO, et al. Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains. Sci Rep. 2017;7(1):5610. doi: 10.1038/s41598-017-06024-2.</mixed-citation><mixed-citation xml:lang="en">Chabert A, Damien P, Verhoeven PO, et al. Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains. Sci Rep. 2017;7(1):5610. doi: 10.1038/s41598-017-06024-2.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sieradzki K, Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol. 1997;179(8):2557-2566. doi: 10.1128/jb.179.8.2557-2566.1997.</mixed-citation><mixed-citation xml:lang="en">Sieradzki K, Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol. 1997;179(8):2557-2566. doi: 10.1128/jb.179.8.2557-2566.1997.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">El-Mowafy SA, Abd El Galil KH, El-Messery SM, Shaaban MI. Aspirin is an efficient inhibitor of quorum sensing, virulence and toxins in Pseudomonas aeruginosa. Microb Pathog. 2014;74:25-32. doi: 10.1016/j.micpath.2014.07.008.</mixed-citation><mixed-citation xml:lang="en">El-Mowafy SA, Abd El Galil KH, El-Messery SM, Shaaban MI. Aspirin is an efficient inhibitor of quorum sensing, virulence and toxins in Pseudomonas aeruginosa. Microb Pathog. 2014;74:25-32. doi: 10.1016/j.micpath.2014.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abidi SH, Ahmed K, Kazmi SU. The antibiofilm activity of Acetylsalicylic acid, Mefenamic acid, Acetaminophen against biofilms formed by P. aeruginosa and S. epidermidis. J Pak Med Assoc. 2019;69(10):1493-1495.</mixed-citation><mixed-citation xml:lang="en">Abidi SH, Ahmed K, Kazmi SU. The antibiofilm activity of Acetylsalicylic acid, Mefenamic acid, Acetaminophen against biofilms formed by P. aeruginosa and S. epidermidis. J Pak Med Assoc. 2019;69(10):1493-1495.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Verma T, Bhaskarla C, Sadhir I, уе фд. Non-steroidal anti-inflammatory drugs, acetaminophen and ibuprofen, induce phenotypic antibiotic resistance in Escherichia coli: roles of marA and acrB. FEMS Microbiol Lett. 2018;365(22). doi: 10.1093/femsle/fny251.</mixed-citation><mixed-citation xml:lang="en">Verma T, Bhaskarla C, Sadhir I, уе фд. Non-steroidal anti-inflammatory drugs, acetaminophen and ibuprofen, induce phenotypic antibiotic resistance in Escherichia coli: roles of marA and acrB. FEMS Microbiol Lett. 2018;365(22). doi: 10.1093/femsle/fny251.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Paes Leme RC, da Silva RB. Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing. Front Microbiol. 2021;12:707629. doi: 10.3389/fmicb.2021.707629.</mixed-citation><mixed-citation xml:lang="en">Paes Leme RC, da Silva RB. Antimicrobial Activity of Non-steroidal Anti-inflammatory Drugs on Biofilm: Current Evidence and Potential for Drug Repurposing. Front Microbiol. 2021;12:707629. doi: 10.3389/fmicb.2021.707629.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
